Clinical Trials

A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma


Study ID
Incyte INCMGA 0012-201

NCT Number
NCT03599713 (Click on the NCT number for more information about the trial)

Research Study Number
2018-0698

Principle Investigator
Dr. Andrew Pecora

Phase
II

Sponsor
Incyte Corporation


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now